Integrated analysis of 8-week glecaprevir/pibrentasvir in Japanese and overseas patients without cirrhosis and with hepatitis C virus genotype 1 or 2 infection

Naganuma A, Chayama K, Notsumata K, et al. Integrated analysis of 8-week glecaprevir/pibrentasvir in Japanese and overseas patients without cirrhosis and with hepatitis C virus genotype 1 or 2 infection. J Gastroenterol. 2019;54(8):752-761.

Publication Type:

Journal Article

Authors:

Naganuma, A; Chayama, K; Notsumata, K; et, al

Source:

J Gastroenterol, Volume 54, Issue 8, p.752-761 (2019)

Cited On:

Export Citation:
RIS Format
Top